Cognitine Adverse Reactions

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing Brand Resources

The information highlighted (if any) are the most recent updates for this brand.

Full Prescribing Info

Adverse Reactions

The reported adverse events in Memantine hydrochloride trials reflect experience gained under closely monitored conditions in a highly selected patient population. In actual practice or in other clinical trials, these frequency estimates may not apply, as the conditions of use, reporting behavior and the types of patients treated may differ. Table below lists treatment-emergent signs and symptoms that were reported in at least 2% of patients in placebo-controlled dementia trials and for which the rate of occurrence was greater for patients treated with Memantine than for those treated with placebo. No adverse event occurred at a frequency of at least 5% and twice the placebo rate. See Table 2.

Click on icon to see table/diagram/image

View ADR Monitoring Form

memantine

Manufacturer:

Korea United Pharma

Distributor:

Littman